No products
Product successfully added to your shopping cart
There are 0 items in your cart. There is 1 item in your cart.
View larger
ORPA-ULTRA
ORPA-ULTRA is a refined variation on th ORPA-OX platform to create a stronger Optimized Xtract with similar qualities. ORPA-ULTRA is a moderate partial agonist at the MOR and DOR that demonstrates a clean efficacy free from adverse effects, tolerance, and addiction potential.
Research Indications: Analgesia, Opioidergic, Antidepressant/Mood Elevation, Anxiolytic/Social Anxiety Disorder
In Stock
More info
ORPA-ULTRA is a refined variation on th ORPA-OX platform to create a stronger Optimized Xtract with similar qualities.
ORPA-ULTRA is a moderate partial agonist at the MOR (mu-opioid receptor) and DOR (delta-opioid receptor) that demonstrates a clean efficacy free from adverse effects, tolerance, and addiction potential.
Research Indications: Analgesia, Opioidergic, Antidepressant/Mood Elevation, Anxiolytic/Social Anxiety Disorder
Projected Human Trial Protocols and Projections"
Dose arms of 25mg, 50mg, and 100mg for moderate analgesia, pronounced mood elevation, and significant social anxiety disorder attenuation. As well, indications show to demonstrate uplifted sense of energy and no potentials for sedation.
USAGE: For Research Use Only! Not For Use in Human